Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susana Ortiz-Urda

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Oncotarget|May 11, 2013
NRAS mutant melanoma--undrugable?Christian Posch, Susana Ortiz-Urda
Skin Health and Disease|June 7, 2024
Lichen sclerosus of the eyelid involving the eyelash marginTiffany Ho, Susana Ortiz Urda, Ryan S Berry
Clinical, Cosmetic and Investigational Dermatology|September 9, 2015
Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradoxAlina Goldenberg, Igor Vujic, Martina Sanlorenzo, et al.
Seminars in Cutaneous Medicine and Surgery|May 30, 2012
Cutting edge in medical management of cutaneous oncologyKim Chong, Adil Daud, Susana Ortiz-Urda, et al.
Melanoma Management|September 8, 2018
New insights in melanoma biomarkers: long-noncoding RNAsRicardo Moreno-Traspas, Igor Vujic, Martina Sanlorenzo, et al.
Chemical Communications (Cambridge, England)|February 6, 2014
Single-point mutation detection in RNA extracts using gold nanoparticles modified with hydrophobic molecular beacon-like structuresAlfonso Latorre, Christian Posch, Yolanda Garcimartín, et al.
Oncotarget|November 9, 2018
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomasChristian Posch, Martina Sanlorenzo, Jeffrey Ma, et al.
The Journal of Investigative Dermatology|May 11, 2016
Searching for the Chokehold of NRAS Mutant MelanomaChristian Posch, Igor Vujic, Babak Monshi, et al.
Plos One|September 9, 2014
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanomaPatti Curl, Igor Vujic, Laura J van 't Veer, et al.
Human Gene Therapy|June 28, 2003
PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosaSusana Ortiz-Urda, Bhaskar Thyagarajan, Douglas R Keene, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|May 11, 2013
NRAS mutant melanoma--undrugable?Christian Posch, Susana Ortiz-Urda
Skin Health and Disease|June 7, 2024
Lichen sclerosus of the eyelid involving the eyelash marginTiffany Ho, Susana Ortiz Urda, Ryan S Berry
Clinical, Cosmetic and Investigational Dermatology|September 9, 2015
Melanoma risk perception and prevention behavior among African-Americans: the minority melanoma paradoxAlina Goldenberg, Igor Vujic, Martina Sanlorenzo, et al.
Seminars in Cutaneous Medicine and Surgery|May 30, 2012
Cutting edge in medical management of cutaneous oncologyKim Chong, Adil Daud, Susana Ortiz-Urda, et al.
Melanoma Management|September 8, 2018
New insights in melanoma biomarkers: long-noncoding RNAsRicardo Moreno-Traspas, Igor Vujic, Martina Sanlorenzo, et al.
Chemical Communications (Cambridge, England)|February 6, 2014
Single-point mutation detection in RNA extracts using gold nanoparticles modified with hydrophobic molecular beacon-like structuresAlfonso Latorre, Christian Posch, Yolanda Garcimartín, et al.
Oncotarget|November 9, 2018
MEK/CDK4,6 co-targeting is effective in a subset of NRAS, BRAF and 'wild type' melanomasChristian Posch, Martina Sanlorenzo, Jeffrey Ma, et al.
The Journal of Investigative Dermatology|May 11, 2016
Searching for the Chokehold of NRAS Mutant MelanomaChristian Posch, Igor Vujic, Babak Monshi, et al.
Plos One|September 9, 2014
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanomaPatti Curl, Igor Vujic, Laura J van 't Veer, et al.
Human Gene Therapy|June 28, 2003
PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosaSusana Ortiz-Urda, Bhaskar Thyagarajan, Douglas R Keene, et al.
Pageof 4